the efficacy of ceftazidime , a new broad-spectrum cephalosporin , active also against pseudomonas aeruginosa , was tested in 19 patients suffering from severe , nonpulmonary localized or systemic infections , which were associated for the most part with concurrent diseases that often had already been unsuccessfully treated with other antibiotics .
C0007559
ceftazidime
C0243026
systemic infections